这是一篇来自已证抗体库的有关
人类 CD226的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD226 抗体。
CD226 同义词: DNAM-1; DNAM1; PTA1; TLiSA1
BioLegend
小鼠 单克隆(11A8) | | BioLegend CD226抗体(BioLegend, 338312)被用于被用于流式细胞仪在人类样本上 (图 s2). BMC Cancer (2019) ncbi |
小鼠 单克隆(11A8) | | BioLegend CD226抗体(Biolegend, 11A8)被用于被用于流式细胞仪在人类样本上 (图 2a). Front Immunol (2019) ncbi |
小鼠 单克隆(11A8) | | BioLegend CD226抗体(BioLegend, 11A8)被用于被用于流式细胞仪在人类样本上 (图 s5a). Proc Natl Acad Sci U S A (2017) ncbi |
小鼠 单克隆(11A8) | | BioLegend CD226抗体(Biolegend, 338304)被用于被用于流式细胞仪在人类样本上 (图 7). Sci Rep (2016) ncbi |
伯乐(Bio-Rad)公司
小鼠 单克隆(DX11) | | 伯乐(Bio-Rad)公司 CD226抗体(Serotec, DX11)被用于被用于抑制或激活实验在人类样本上 (图 2). BMC Cancer (2015) ncbi |
碧迪BD
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Pharmingen, DX11)被用于被用于流式细胞仪在人类样本上 (图 5a). Front Immunol (2019) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Pharmingen, DX11)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncoimmunology (2017) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于抑制或激活实验在人类样本上 (图 5). J Exp Med (2017) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Bioscience, DX11)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Pharmingen, DX11)被用于被用于流式细胞仪在人类样本上 (图 5c). J Biol Chem (2016) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2016) ncbi |
小鼠 单克隆(DX11) | - 抑制或激活实验; 人类; 图 s9a
- 流式细胞仪; 人类
| 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于抑制或激活实验在人类样本上 (图 s9a) 和 被用于流式细胞仪在人类样本上. Nat Commun (2016) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 2). Methods Mol Biol (2016) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD, 559789)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (表 1). Cancer Immunol Immunother (2015) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2015) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD, DX11)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi |
小鼠 单克隆(DX11) | | 碧迪BD CD226抗体(BD, DX11)被用于被用于免疫印迹在人类样本上. Clin Cancer Res (2014) ncbi |
Choi J, Lee E, Kim S, Park S, Oh S, Kang J,
et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817
pubmed 出版商
Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N,
et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957
pubmed 出版商
Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T,
et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496
pubmed 出版商
Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443
pubmed 出版商
Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586
pubmed 出版商
Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D,
et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841
pubmed 出版商
Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A,
et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354
pubmed 出版商
Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L,
et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636
pubmed 出版商
Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71
pubmed 出版商
Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52
pubmed 出版商
Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J,
et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96
pubmed 出版商
Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C,
et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686
pubmed 出版商
Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30
pubmed 出版商
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商
Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A,
et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83
pubmed 出版商
Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E,
et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71
pubmed 出版商
Fionda C, Abruzzese M, Zingoni A, Soriani A, Ricci B, Molfetta R,
et al. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation. BMC Cancer. 2015;15:17
pubmed 出版商
Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D,
et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202
pubmed 出版商
Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M,
et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94
pubmed 出版商